Relating to post-exposure prophylaxes.

Requires hospitals to adopt policies and procedures to ensure provision of human immunodeficiency virus post-exposure prophylactic drugs or therapies following patient's possible exposure to human immunodeficiency virus. Requires Oregon Health Authority, once per year, to provide 30-day supply of prophylactic drugs or therapies to each type A and type B hospital, unless declined by hospital, at no cost to hospital. Prohibits health benefit plan from imposing deductibles, copayments, coinsurance or other cost-sharing on coverage of human immunodeficiency virus post-exposure prophylactic drugs or therapies following enrollee's possible exposure to human immunodeficiency virus.